105 related articles for article (PubMed ID: 27387593)
1. Serine Protease Catalysis: A Computational Study of Tetrahedral Intermediates and Inhibitory Adducts.
Ngo PD; Mansoorabadi SO; Frey PA
J Phys Chem B; 2016 Aug; 120(30):7353-9. PubMed ID: 27387593
[TBL] [Abstract][Full Text] [Related]
2. 11B NMR spectroscopy of peptide boronic acid inhibitor complexes of alpha-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes.
Tsilikounas E; Kettner CA; Bachovchin WW
Biochemistry; 1993 Nov; 32(47):12651-5. PubMed ID: 8251483
[TBL] [Abstract][Full Text] [Related]
3. Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes.
Bachovchin WW; Wong WY; Farr-Jones S; Shenvi AB; Kettner CA
Biochemistry; 1988 Oct; 27(20):7689-97. PubMed ID: 3207700
[TBL] [Abstract][Full Text] [Related]
4. Crystal versus solution structure of enzymes: NMR spectroscopy of a peptide boronic acid-serine protease complex in the crystalline state.
Farr-Jones S; Smith SO; Kettner CA; Griffin RG; Bachovchin WW
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):6922-4. PubMed ID: 2780549
[TBL] [Abstract][Full Text] [Related]
5. Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by 1H NMR spectroscopy.
Tsilikounas E; Kettner CA; Bachovchin WW
Biochemistry; 1992 Dec; 31(51):12839-46. PubMed ID: 1463754
[TBL] [Abstract][Full Text] [Related]
6. Serine protease mechanism: structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid.
Bone R; Shenvi AB; Kettner CA; Agard DA
Biochemistry; 1987 Dec; 26(24):7609-14. PubMed ID: 3122831
[TBL] [Abstract][Full Text] [Related]
7. Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein.
Zervosen A; Herman R; Kerff F; Herman A; Bouillez A; Prati F; Pratt RF; Frère JM; Joris B; Luxen A; Charlier P; Sauvage E
J Am Chem Soc; 2011 Jul; 133(28):10839-48. PubMed ID: 21574608
[TBL] [Abstract][Full Text] [Related]
8. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond.
Cassidy CS; Lin J; Frey PA
Biochemistry; 1997 Apr; 36(15):4576-84. PubMed ID: 9109667
[TBL] [Abstract][Full Text] [Related]
9. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
10. Subangstrom crystallography reveals that short ionic hydrogen bonds, and not a His-Asp low-barrier hydrogen bond, stabilize the transition state in serine protease catalysis.
Fuhrmann CN; Daugherty MD; Agard DA
J Am Chem Soc; 2006 Jul; 128(28):9086-102. PubMed ID: 16834383
[TBL] [Abstract][Full Text] [Related]
11. X-ray snapshots of serine protease catalysis reveal a tetrahedral intermediate.
Wilmouth RC; Edman K; Neutze R; Wright PA; Clifton IJ; Schneider TR; Schofield CJ; Hajdu J
Nat Struct Biol; 2001 Aug; 8(8):689-94. PubMed ID: 11473259
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary relationships between seryl-histidine dipeptide and modern serine proteases from the analysis based on mass spectrometry and bioinformatics.
Liu Y; Li YB; Gao X; Yu YF; Liu XX; Ji ZL; Ma Y; Li YM; Zhao YF
Amino Acids; 2018 Jan; 50(1):69-77. PubMed ID: 29071530
[TBL] [Abstract][Full Text] [Related]
13. Insights into the serine protease mechanism based on structural observations of the conversion of a peptidyl serine protease inhibitor to a substrate.
Jiang L; Andersen LM; Andreasen PA; Chen L; Huang M
Biochim Biophys Acta; 2016 Mar; 1860(3):599-606. PubMed ID: 26691138
[TBL] [Abstract][Full Text] [Related]
14. Low-barrier hydrogen bonds and enzymatic catalysis.
Cleland WW
Arch Biochem Biophys; 2000 Oct; 382(1):1-5. PubMed ID: 11051090
[TBL] [Abstract][Full Text] [Related]
15. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF
Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates.
Bone R; Frank D; Kettner CA; Agard DA
Biochemistry; 1989 Sep; 28(19):7600-9. PubMed ID: 2611204
[TBL] [Abstract][Full Text] [Related]
17. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin.
Lin J; Cassidy CS; Frey PA
Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318
[TBL] [Abstract][Full Text] [Related]
18. Cysteine proteases such as papain are not inhibited by substrate analogue peptidyl boronic acids.
Martichonok V; Jones JB
Bioorg Med Chem; 1997 Apr; 5(4):679-84. PubMed ID: 9158866
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl boronates inhibit Salmonella enterica serovar Typhimurium Lon protease by a competitive ATP-dependent mechanism.
Frase H; Lee I
Biochemistry; 2007 Jun; 46(22):6647-57. PubMed ID: 17497890
[TBL] [Abstract][Full Text] [Related]
20. The 1.8 A structure of the complex between chymostatin and Streptomyces griseus protease A. A model for serine protease catalytic tetrahedral intermediates.
Delbaere LT; Brayer GD
J Mol Biol; 1985 May; 183(1):89-103. PubMed ID: 3892018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
